Colgate-Palmolive Co.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $20.80B | $20.10B | $19.50B | $18.00B | $17.40B | $16.50B | $15.70B |
| Oral, Personal and Home Care | — | $16.00B | $15.50B | $15.10B | $14.30B | $14.10B | $13.20B | $12.70B |
| Hill's Pet Nutrition | — | $4.80B | $4.60B | $4.40B | $3.70B | $3.30B | $3.30B | $3.00B |
| Cost of Revenue | — | $8.13B | $7.94B | $8.13B | $7.72B | $7.05B | $6.45B | $6.37B |
| Gross Profit | — | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.33B |
| Gross Margin | — | 58.9% | 60.5% | 58.1% | 56.9% | 59.6% | 60.7% | 59.4% |
| Operating Expenses | ||||||||
| Research & Development | — | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M | $290.0M | $281.0M |
| SG&A Expense | — | $7.90B | $7.73B | $7.15B | $6.57B | $6.41B | $6.02B | $5.58B |
| Operating Income | — | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.89B | $3.55B |
| Operating Margin | — | 15.9% | 21.2% | 20.4% | 16.1% | 19.1% | 23.5% | 22.6% |
| Interest Expense | — | — | — | $299.0M | $172.0M | $120.0M | $184.0M | $193.0M |
| Pretax Income | — | $3.06B | $3.96B | $3.39B | $2.66B | $3.09B | $3.65B | $3.30B |
| Income Tax Expense | — | $798.0M | $907.0M | $937.0M | $693.0M | $749.0M | $787.0M | $774.0M |
| Net Income | — | $2.13B | $2.89B | $2.30B | $1.79B | $2.17B | $2.70B | $2.37B |
| Net Margin | — | 10.3% | 14.4% | 11.8% | 9.9% | 12.4% | 16.3% | 15.1% |
| EPS (Basic) | — | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 | $3.15 | $2.76 |
| EPS (Diluted) | — | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 |
| Shares Outstanding (Basic) | 801.5M | 808.7M | 819.1M | 827.4M | 836.4M | 845.0M | 856.8M | 859.1M |
| Shares Outstanding (Diluted) | 801.5M | 811.1M | 823.2M | 829.2M | 838.8M | 848.3M | 859.3M | 861.1M |
| Dividends Per Share | — | $2.08 | $2.48 | $1.91 | $1.86 | $1.79 | $1.75 | $1.71 |